Signatures of mutational processes in human cancerTon N. Schumacher, Birgit Burkhardt, Adam P. Butler et al.|Nature|2013Cited by 10.1k
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variantsDaniel R. Barnes, Hélène Schuster, Matti A. Rookus et al.|Genetics in Medicine|2020Cited by 145
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancerManuel A. R. Ferreira, Jackie Cook, Eric R. Gamazon et al.|Nature Communications|2019Cited by 138
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragilityIrene Catucci, Paolo Peterlongo, Ana Osório et al.|Genetics in Medicine|2017Cited by 93
Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibilityTuomo Mantere, Katri Pylkäs, Anna Tervasmäki et al.|Scientific Reports|2017Cited by 37